Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19924384rdf:typepubmed:Citationlld:pubmed
pubmed-article:19924384lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:19924384lifeskim:mentionsumls-concept:C0169539lld:lifeskim
pubmed-article:19924384lifeskim:mentionsumls-concept:C0280100lld:lifeskim
pubmed-article:19924384lifeskim:mentionsumls-concept:C0378796lld:lifeskim
pubmed-article:19924384lifeskim:mentionsumls-concept:C0031325lld:lifeskim
pubmed-article:19924384lifeskim:mentionsumls-concept:C1268567lld:lifeskim
pubmed-article:19924384lifeskim:mentionsumls-concept:C2605895lld:lifeskim
pubmed-article:19924384pubmed:issue1lld:pubmed
pubmed-article:19924384pubmed:dateCreated2011-1-4lld:pubmed
pubmed-article:19924384pubmed:abstractTextTelatinib is an orally active small-molecule tyrosine kinase inhibitor of kinase insert domain receptor (KDR; VEGFR-2) and fms-related tyrosine kinase 4 (FLT4; VEGFR-3). This study aims at the identification of relationships between single nucleotide polymorphisms (SNPs) in genes encoding for transporter proteins and pharmacokinetic parameters in order to clarify the significant interpatient variability in drug exposure. In addition, the potential relationship between target receptor polymorphisms and toxicity of telatinib is explored.lld:pubmed
pubmed-article:19924384pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19924384pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19924384pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19924384pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19924384pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19924384pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19924384pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19924384pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19924384pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19924384pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19924384pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19924384pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19924384pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19924384pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19924384pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19924384pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19924384pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19924384pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19924384pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19924384pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19924384pubmed:languageenglld:pubmed
pubmed-article:19924384pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19924384pubmed:citationSubsetIMlld:pubmed
pubmed-article:19924384pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19924384pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19924384pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19924384pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19924384pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19924384pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19924384pubmed:statusMEDLINElld:pubmed
pubmed-article:19924384pubmed:monthFeblld:pubmed
pubmed-article:19924384pubmed:issn1573-0646lld:pubmed
pubmed-article:19924384pubmed:authorpubmed-author:GelderblomHan...lld:pubmed
pubmed-article:19924384pubmed:authorpubmed-author:GuchelaarHenk...lld:pubmed
pubmed-article:19924384pubmed:authorpubmed-author:NortierJohan...lld:pubmed
pubmed-article:19924384pubmed:authorpubmed-author:EskensFerry...lld:pubmed
pubmed-article:19924384pubmed:authorpubmed-author:de...lld:pubmed
pubmed-article:19924384pubmed:authorpubmed-author:SteeghsNeeltj...lld:pubmed
pubmed-article:19924384pubmed:authorpubmed-author:WesselsJudith...lld:pubmed
pubmed-article:19924384pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19924384pubmed:volume29lld:pubmed
pubmed-article:19924384pubmed:ownerNLMlld:pubmed
pubmed-article:19924384pubmed:authorsCompleteYlld:pubmed
pubmed-article:19924384pubmed:pagination137-43lld:pubmed
pubmed-article:19924384pubmed:dateRevised2011-7-25lld:pubmed
pubmed-article:19924384pubmed:meshHeadingpubmed-meshheading:19924384...lld:pubmed
pubmed-article:19924384pubmed:meshHeadingpubmed-meshheading:19924384...lld:pubmed
pubmed-article:19924384pubmed:meshHeadingpubmed-meshheading:19924384...lld:pubmed
pubmed-article:19924384pubmed:meshHeadingpubmed-meshheading:19924384...lld:pubmed
pubmed-article:19924384pubmed:meshHeadingpubmed-meshheading:19924384...lld:pubmed
pubmed-article:19924384pubmed:meshHeadingpubmed-meshheading:19924384...lld:pubmed
pubmed-article:19924384pubmed:meshHeadingpubmed-meshheading:19924384...lld:pubmed
pubmed-article:19924384pubmed:meshHeadingpubmed-meshheading:19924384...lld:pubmed
pubmed-article:19924384pubmed:meshHeadingpubmed-meshheading:19924384...lld:pubmed
pubmed-article:19924384pubmed:meshHeadingpubmed-meshheading:19924384...lld:pubmed
pubmed-article:19924384pubmed:meshHeadingpubmed-meshheading:19924384...lld:pubmed
pubmed-article:19924384pubmed:meshHeadingpubmed-meshheading:19924384...lld:pubmed
pubmed-article:19924384pubmed:meshHeadingpubmed-meshheading:19924384...lld:pubmed
pubmed-article:19924384pubmed:meshHeadingpubmed-meshheading:19924384...lld:pubmed
pubmed-article:19924384pubmed:meshHeadingpubmed-meshheading:19924384...lld:pubmed
pubmed-article:19924384pubmed:meshHeadingpubmed-meshheading:19924384...lld:pubmed
pubmed-article:19924384pubmed:meshHeadingpubmed-meshheading:19924384...lld:pubmed
pubmed-article:19924384pubmed:year2011lld:pubmed
pubmed-article:19924384pubmed:articleTitlePharmacogenetics of telatinib, a VEGFR-2 and VEGFR-3 tyrosine kinase inhibitor, used in patients with solid tumors.lld:pubmed
pubmed-article:19924384pubmed:affiliationDepartment of Clinical Oncology, Leiden University Medical Centre, K1-P, P.O Box 9600, 2300 RC, Leiden, The Netherlands.lld:pubmed
pubmed-article:19924384pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19924384pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:19924384pubmed:publicationTypeClinical Trial, Phase Illd:pubmed
entrez-gene:3791entrezgene:pubmedpubmed-article:19924384lld:entrezgene
entrez-gene:4363entrezgene:pubmedpubmed-article:19924384lld:entrezgene
entrez-gene:5243entrezgene:pubmedpubmed-article:19924384lld:entrezgene
entrez-gene:2324entrezgene:pubmedpubmed-article:19924384lld:entrezgene
entrez-gene:9429entrezgene:pubmedpubmed-article:19924384lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:19924384lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:19924384lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:19924384lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:19924384lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:19924384lld:entrezgene